Over the past 12 months, 4 insiders at Adaptimmune Therapeutics PLC filed 6 open-market SEC Form 4 transactions on ADAP: 0 purchases worth $0 and 6 sales worth $3.2M. Insiders have been net sellers over this period. The most recent filing was on Sep 2, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 25 | Gavin WoodChief Financial Officer | SELL | 96.0K | $0.01 | $960 |
| Aug 28, 25 | William C Bertrand JrChief Operating Officer | SELL | 207.0K | $0.01 | $2K |
| Aug 18, 25 | Ali BehbahaniDirector | SELL | 14.67M | $0.01 | $147K |
| Aug 15, 25 | Ali BehbahaniDirector | SELL | 4.83M | $0.01 | $48K |
| Jul 30, 25 | Ecor1 Capital, LlcTenPercentOwner | SELL | 27.43M | $0.10 | $2.7M |
| Jul 29, 25 | Ecor1 Capital, LlcTenPercentOwner | SELL | 2.69M | $0.10 | $269K |
| Jul 28, 25 | Ecor1 Capital, LlcTenPercentOwner | SELL | 33.93M | $0.11 | $3.7M |
| Jan 17, 25 | William C Bertrand JrChief Operating Officer | SELL | 5.6K | $0.58 | $3K |
| Jan 17, 25 | John LungerChief Patient Supply Officer | SELL | 5.6K | $0.58 | $3K |
| Jan 17, 25 | Elliot NorryChief Medical Officer | SELL | 5.6K | $0.58 | $3K |
| Jan 17, 25 | Adrian RawcliffeChief Executive Officer | SELL | 30.6K | $0.58 | $18K |
| Jan 15, 25 | Cintia PiccinaChief Commercial Officer | SELL | 13.0K | $0.57 | $7K |
| Jan 15, 25 | William C Bertrand JrChief Operating Officer | SELL | 9.8K | $0.57 | $6K |
| Jan 15, 25 | John LungerChief Patient Supply Officer | SELL | 9.8K | $0.57 | $6K |
| Jan 15, 25 | Elliot NorryChief Medical Officer | SELL | 9.8K | $0.57 | $6K |
| Jan 15, 25 | Adrian RawcliffeChief Executive Officer | SELL | 29.1K | $0.57 | $17K |
| Jan 13, 25 | William C Bertrand JrChief Operating Officer | SELL | 5.5K | $0.59 | $3K |
| Jan 13, 25 | John LungerChief Patient Supply Officer | SELL | 5.5K | $0.59 | $3K |
| Jan 13, 25 | Elliot NorryChief Medical Officer | SELL | 8.1K | $0.59 | $5K |
| Jan 13, 25 | Adrian RawcliffeChief Executive Officer | SELL | 17.9K | $0.59 | $11K |
| Jun 18, 24 | Cintia PiccinaChief Commercial Officer | SELL | 24.5K | $0.93 | $23K |
| Jan 17, 24 | William C Bertrand JrChief Operating Officer | SELL | 13.6K | $0.67 | $9K |
| Jan 17, 24 | John LungerChief Patient Supply Officer | SELL | 12.8K | $0.67 | $9K |
| Jan 17, 24 | Elliot NorryChief Medical Officer | SELL | 13.0K | $0.67 | $9K |
| Jan 17, 24 | Adrian RawcliffeChief Executive Officer | SELL | 30.1K | $0.67 | $20K |
| Jan 16, 24 | William C Bertrand JrChief Operating Officer | SELL | 4.7K | $0.79 | $4K |
| Jan 16, 24 | John LungerChief Patient Supply Officer | SELL | 4.7K | $0.79 | $4K |
| Jan 16, 24 | Elliot NorryChief Medical Officer | SELL | 2.3K | $0.79 | $2K |
| Jan 16, 24 | Adrian RawcliffeChief Executive Officer | SELL | 9.3K | $0.79 | $7K |
| Jan 12, 24 | William C Bertrand JrChief Operating Officer | SELL | 5.2K | $0.85 | $4K |
| Jan 12, 24 | John LungerChief Patient Supply Officer | SELL | 5.2K | $0.85 | $4K |
| Jan 12, 24 | Elliot NorryChief Medical Officer | SELL | 7.8K | $0.85 | $7K |
| Jan 12, 24 | Adrian RawcliffeChief Executive Officer | SELL | 17.3K | $0.85 | $15K |
| Jan 11, 24 | William C Bertrand JrChief Operating Officer | SELL | 4.0K | $0.84 | $3K |
| Jan 11, 24 | John LungerChief Patient Supply Officer | SELL | 4.0K | $0.84 | $3K |
| Jan 11, 24 | Elliot NorryChief Medical Officer | SELL | 4.0K | $0.84 | $3K |
| Jan 11, 24 | Adrian RawcliffeChief Executive Officer | SELL | 11.9K | $0.84 | $10K |
| Sep 1, 23 | Adrian RawcliffeChief Executive Officer | SELL | 2.4K | $0.78 | $2K |
| Aug 1, 23 | John LungerChief Patient Supply Officer | SELL | 3.1K | $0.91 | $3K |
| Jul 10, 23 | Garry E MenzelDirector | SELL | 47.7K | $0.91 | $43K |
| Jun 27, 23 | Adrian RawcliffeChief Executive Officer | SELL | 2.3K | $0.92 | $2K |
| Jan 31, 23 | Cintia PiccinaChief Commercial Officer | SELL | 11.9K | $1.87 | $22K |
| Jan 17, 23 | William C Bertrand JrChief Operating Officer | SELL | 4.4K | $1.86 | $8K |
| Jan 17, 23 | John LungerChief Patient Supply Officer | SELL | 4.4K | $1.86 | $8K |
| Jan 17, 23 | Elliot NorryChief Medical Officer | SELL | 2.2K | $1.86 | $4K |
| Jan 17, 23 | Adrian RawcliffeChief Executive Officer | SELL | 10.1K | $1.86 | $19K |
| Jan 12, 23 | William C Bertrand JrChief Operating Officer | SELL | 5.0K | $1.71 | $9K |
| Jan 12, 23 | John LungerChief Patient Supply Officer | SELL | 5.0K | $1.71 | $9K |
| Jan 12, 23 | Elliot NorryChief Medical Officer | SELL | 7.4K | $1.71 | $13K |
| Jan 12, 23 | Adrian RawcliffeChief Executive Officer | SELL | 18.8K | $1.71 | $32K |
Over the past 12 months, insiders at Adaptimmune Therapeutics PLC filed 0 open-market purchases worth $0 and 6 sales worth $3.2M on ADAP, which makes them net sellers over the period. The most recent Form 4 was filed on Sep 2, 25.
4 different insiders at Adaptimmune Therapeutics PLC filed open-market SEC Form 4 transactions on ADAP over the last 12 months.
InsiderTape plots every ADAP insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Adaptimmune Therapeutics PLC insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →